We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Fresher Blood Donations May Be Better for Recipients

By LabMedica International staff writers
Posted on 14 Nov 2013
A modernized blood management system similar to inventory management systems could greatly reduce blood storage time and potentially reduce the risk of complications for the patient.

Red blood cells (RBCs) undergo biochemical and morphologic changes during storage, and evidence suggests that the longer the RBC product is stored, the less effective is the transfused blood.

A team of clinical scientists the Cleveland Clinic (Cleveland, OH, USA) reviewed existing literature to examine the presence of storage-related complications in patients who underwent blood transfusions. More...
They found several studies in trauma and cardiac surgery that linked increased blood storage duration to post-injury multiple organ failure, infection, deep vein thrombosis, and hospital mortality, while other studies reported no apparent relationship between storage duration and clinical outcomes.

Several ongoing randomized controlled trials may answer more questions in the future. Meanwhile, the scientists recommend exploring changes to the current first-in, first-out process. They pointed to new models of inventory management in the retail sector that would reduce inventory shelf time in favor of just-in-time delivery of products. One existing model involves blood platelet donation. Platelets expire five days after donation, so managing platelet inventory requires hourly monitoring and more frequent deliveries from blood collection agencies. These same techniques could be used for red blood cell donations and help reduce blood storage duration to 14 days or less.

Colleen G. Koch, MD, MS, MBA, the senior author of the study said, “We recommend further work with inventory management to explore strategies that would optimize fresher blood for patients. Until results of ongoing randomized controlled trials in the area of storage duration are completed, we cannot recommend a change in the current US Food and Drug Administration (FDA, Silver Springs, MD, USA) formal guidelines; however, we encourage surgeons to remain aware of the possible complications associated with red blood cell transfusion.” The study was published on October 31, 2013, in the journal the Annals of Thoracic Surgery.

Related Links:

Cleveland Clinic
US Food and Drug Administration 



New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
Online QC Software
Acusera 24•7
New
Benchtop Thermomixer
Biometra TS1 ThermoShaker
New
Prefilled Tubes
Prefilled 5.0ml Tubes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Roche’s CE-Marked Elecsys pTau217 blood test is a single‑assay blood test measures phosphorylated tau 217, an indicator of amyloid pathology and a hallmark of Alzheimer’s disease (image credit: Shutterstock)

Blood-Based Alzheimer’s Test Gains CE Mark for Amyloid Pathology Detection

Alzheimer’s disease is the most common cause of dementia, yet confirmatory testing remains invasive and hard to access. Diagnosis currently takes an average of 3.5 years, and about 75% of people with dementia... Read more

Molecular Diagnostics

view channel
Image: Clarifying tumor microenvironment features and cancer-cell programs linked to treatment response could provide earlier insight into triple-negative breast cancer therapy (image credit: Shutterstock)

Gene Panel Shows Promise for Predicting Chemotherapy Response in TNBC

Triple-negative breast cancer (TNBC) is an aggressive subtype commonly treated with chemotherapy, yet outcomes vary widely among patients. Understanding the tumor features that drive this variability remains... Read more

Microbiology

view channel
Image: The initiative combines epidemiological and microbiological data with whole-genome sequencing to characterize circulating hospital lineages and resistance determinants (image credit: Shutterstock)

Large-Scale Genomic Surveillance Tracks Resistant Bacteria Across European Hospitals

Antimicrobial resistance (AMR) poses a growing threat to patient safety, with carbapenem-resistant Enterobacterales causing difficult-to-treat infections and leaving clinicians with limited therapeutic options.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.